HTL-001

N/A

Report date: 2024/11/26 17:11:34

NME

Base Information

Drug NameHTL-001

Drug Alias NameHTL-001

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionHOX and PBX interaction inhibitor

TargetsHomeodomain Proteins

Therapy Area/IndicationsBrain Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsBrain Neoplasms

Inactive IndicationsN/A

ATC CodeN/A